Literature DB >> 26613884

Assessment of Musculoskeletal Malignancies with Functional MR Imaging.

Joan C Vilanova1, Sandra Baleato-Gonzalez2, Maria José Romero3, Javier Carrascoso-Arranz4, Antonio Luna5.   

Abstract

Functional MR imaging is the technique of choice to evaluate and manage malignant musculoskeletal masses. Advanced MR imaging sequences include chemical shift MR imaging, diffusion-weighted imaging with apparent diffusion coefficient mapping, MR spectroscopy imaging, and dynamic contrast-enhanced perfusion imaging. Functional MR imaging adds value to morphologic sequences in the detection, characterization, staging, and posttherapy assessment of malignant musculoskeletal malignancies. This article reviews the technical role of each functional sequence and their clinical applications to allow more confident decisions to be made. Multiparametric analysis of functional and anatomic MR sequences allows musculoskeletal tumors analysis to be improved.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone tumors; Diffusion-weighted image; Dynamic contrast-enhanced perfusion imaging; MR imaging; Magnetic resonance spectroscopy imaging; Malignant skeletal neoplasms; Soft tissue tumors

Mesh:

Substances:

Year:  2015        PMID: 26613884     DOI: 10.1016/j.mric.2015.08.006

Source DB:  PubMed          Journal:  Magn Reson Imaging Clin N Am        ISSN: 1064-9689            Impact factor:   2.266


  8 in total

1.  Multiparametric MRI with diffusion-weighted imaging in predicting response to chemotherapy in cases of osteosarcoma and Ewing's sarcoma.

Authors:  Mahmoud Mohamed Saleh; Tamer Moustafa Abdelrahman; Youusef Madney; Ghada Mohamed; Ahmed Mohammed Shokry; Amr Farouk Moustafa
Journal:  Br J Radiol       Date:  2020-10-15       Impact factor: 3.039

2.  Detection of Soft Tissue Sarcoma Recurrence: Feasibility of Ultrafast 3D Gradient-Echo Sequence in Addition to Conventional Contrast-Enhanced MRI to Provide Early-Phase Postcontrast Information.

Authors:  Hye Min Son; Hye Jin Yoo; Sung Hwan Hong; Ja Young Choi; Hee Dong Chae
Journal:  J Belg Soc Radiol       Date:  2022-05-27       Impact factor: 1.912

3.  Magnetic resonance-guided focused ultrasound for the treatment of painful bone metastases: role of apparent diffusion coefficient (ADC) and dynamic contrast enhanced (DCE) MRI in the assessment of clinical outcome.

Authors:  Michele Anzidei; Alessandro Napoli; Beatrice Sacconi; Fabrizio Boni; Vincenzo Noce; Michele Di Martino; Luca Saba; Carlo Catalano
Journal:  Radiol Med       Date:  2016-08-27       Impact factor: 3.469

4.  [Bone tumors and metastases: tips for initial diagnosis and follow-up : Update 2019].

Authors:  Kolja M Thierfelder; Sophie Niendorf; Judith S Gerhardt; Marc-An Dré Weber
Journal:  Radiologe       Date:  2020-02       Impact factor: 0.635

5.  The safety of primary surgical excision of small deep indeterminate musculoskeletal soft tissue masses.

Authors:  Michèle Calleja; Qasim Afzaal; Asif Saifuddin
Journal:  Br J Radiol       Date:  2020-10-30       Impact factor: 3.039

Review 6.  Imaging features of primary sites and metastatic patterns of angiosarcoma.

Authors:  Basrull N Bhaludin; Khin Thway; Margaret Adejolu; Alexandra Renn; Christian Kelly-Morland; Cyril Fisher; Robin L Jones; Christina Messiou; Eleanor Moskovic
Journal:  Insights Imaging       Date:  2021-12-18

Review 7.  Multiparametric MRI evaluation of bone sarcomas in children.

Authors:  Emilio J Inarejos Clemente; Oscar M Navarro; Maria Navallas; Enrique Ladera; Ferran Torner; Mariona Sunol; Moira Garraus; Jordi Català March; Ignasi Barber
Journal:  Insights Imaging       Date:  2022-03-01

Review 8.  Review of imaging techniques for evaluating morphological and functional responses to the treatment of bone metastases in prostate and breast cancer.

Authors:  J Orcajo-Rincon; J Muñoz-Langa; J M Sepúlveda-Sánchez; G C Fernández-Pérez; M Martínez; E Noriega-Álvarez; S Sanz-Viedma; J C Vilanova; A Luna
Journal:  Clin Transl Oncol       Date:  2022-02-13       Impact factor: 3.340

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.